How Innovation Comes Together: Visiting Heilbronn with BioMedTech e. V.
New approaches to IT education, support for start-ups and an ambitious AI strategy: Heilbronn is pursuing several avenues to drive technological innovation. Our colleague Alexander Kempf joined BioMedTech e. V. on a visit to 42 Heilbronn, Campus Founders and IPAI. The visits also highlighted potential links to biotechnology and medical technology.
How do you create an environment in which technical knowledge translates into viable business models and practical applications? This was the question the visiting group explored in Heilbronn. Three stops showcased distinct yet closely connected approaches: developing skilled professionals, supporting start-ups and creating the conditions for the use of artificial intelligence.
42 Heilbronn: New Approaches to Developing IT Skills
The first stop was 42 Heilbronn. The focus was on an alternative educational model that develops IT skills outside traditional university structures. The visiting group was particularly interested in how such programmes can respond flexibly to emerging technological requirements.
Underlying this approach is a question that extends far beyond the IT sector: how can people be equipped for roles whose requirements are constantly evolving? Biotechnology and medical technology companies also need digital skills to make effective use of data-driven methods and new technologies. Alternative educational pathways can complement existing approaches to workforce development.
Campus Founders: Turning Ideas into Businesses
At Campus Founders, the focus shifted from skills development to entrepreneurship. The introduction to the co-innovation hub highlighted the role a shared working environment can play for start-ups and what tailored support and networking opportunities can look like.
Discussions covered topics including IT security and cloud technologies. These areas offer points of connection for the biomedical technology sector, particularly where sensitive data needs to be processed, digital solutions developed or technical applications translated into viable business models.
Whether and how biotechnology and medical technology could become more closely integrated into this ecosystem is an interesting prospect. While no concrete collaborations have emerged at this stage, the visit identified potential starting points for further dialogue.
IPAI: AI Transformation Requires More Than Technology
The third stop was IPAI, the Innovation Park Artificial Intelligence. The presentation outlined the vision of developing Heilbronn into Europe’s leading hub for artificial intelligence.
A key focus was a holistic approach to transformation. Technical infrastructure alone is not enough to successfully embed AI in businesses and society. Company management, works councils, employees and the wider public must also be involved.
This perspective is particularly relevant to biotechnology and medical technology. Wherever new technologies involve sensitive data, established workflows or medical applications, they raise questions not only about technical feasibility but also about responsibility, acceptance and trust.
Dr. Ulrike Brucklacher und Sören Lauinger vom BioMedTech Verein
/ Copyright: Alexander Kempf/ BioRegio STERN Management GmbHInspiration for the BioMedTech Sector
The visit demonstrated how education, start-up support and AI development can complement one another. Together, they create opportunities to connect skills with entrepreneurial ideas. Automation, in particular, enables the production of customised BioMedTech solutions.
Alexander Kempf’s visit to Heilbronn offered more than insights into individual institutions. The three stops also provided inspiration for how the BioMedTech sector could engage with related fields of technology. The key will be to translate these connections into concrete questions and joint projects.
BioRegio STERN Management GmbH